Pharmacokinetics DiY part 4 (effect compartment control)
The incentive of these pharmacokinetic DiY blogs was to give colleagues that have an interest in pharmacokinetics and pharmacodynamics a relative simple tool to use published pk/pd models and make simulations that can be used to deepen the understanding of the tools like TCI that we use in daily practice to perform anaesthesia. We have used the Euler approximation in a spreadsheet and demonstrated that small steps of 5 seconds could be sufficiently closely matched to the exponential equations and graphs that represent the evolution of drug concentrations in a patient. This was possible for bolus, infusion and target controlled infusion in a deterministic way, in other words: based on calculations that are simple and valid for all drugs simulations. For me these spreadsheets are valuable despite the fact that I have developed Tivatrainer(X) that uses analytical equations and is in theory more accurate. For a quick simulation to verify an idea or concept I still use the spreadsheet approach
Pharmacokinetics DiY part 3 (+Pharmacodynamics)
In part 1 I have explained how a relative simple spreadsheet can produce the concentration of an intravenous drug dose with given pharmacokinetic parameters that describe a 2 or 3 compartment model. In part 2, target controlled infusion(TCI) for blood control has been introduced together with a method to use two pharmcokinetic models in one simulation: the Eleveld model with and without opioid. In this episode I add the effect compartment and the Emax model for the BIS, available in this relative new Eleveld population Pk/Pd model, the first ‘universal’ model for propofol. The principles on which the spreadsheets are built are similar for other drugs. So you could use these spreadsheets with a bit of parameter alteration for Lidocaine, Remifentanil, Sufentanil or whatever other drug that can be modelled with compartimental kinetics. In part 1 I have explained how you can verify your simulations with the original study data by what I called the overlaying technique. If your simulation does
A reflection on the effect site
Last week I was at the dentist needing a minor procedure that involved having a local anaesthetic. As the I was sitting in the dental chair receiving the injection and experiencing the numbness spreading, I was thinking about the effect site. The concept of the effect site was first described by Holford and Sheiner [1] and adopted more recently to explain the observed delay or time differential between a given drug concentration in the whole blood or plasma and its observed effect at that time on the patient. The evolution of this relationship was used to explain changes of intensity of drug effect in relation to increasing or decreasing drug concentrations. In essence, the effect site was conceptualised as a PkPd link model. In intravenous pharmacology of the recent past, describing the effect site has been a common feature in pharmacokinetic and pharmacodynamic modelling, mainly to demonstrate that some drugs have faster and some slower effect site equilibration characteristics. The
Pharmocokinetics DiY part 2
In the pharmacokineticsDiY part 1 the numerical approach of pharmacokinetic calculations was explained. Using relative simple formulas implemented in a spreadsheet the concentrations of a drug could be calculated following variable drug input protocols. The Eleveld model for propofol was used. This was not without a reason. Douglas Eleveld and co-authors analyzed the data from numerous other studies, collected in the open Target Controlled In fusion(TCI) initiative, to develop a pharmacokinetic and pharmacodynamic model for broad application in anaesthesia and sedation. Their work is a milestone in the development of Pk/Pd models that will improve the clinical usability of Target Controlled Infusion systems and the understanding and interpretation of the observed effect related to these models. Until recently most of the implemented models in Target Controlled Infusion systems were limited in usability and hampered by unverified extrapolation of data from studies that were not intended to deliver robust, population models for TCI. So a model for an ‘average’ patient could be unreliable
Pharmacokinetics DiY
part 1:building and verifying the spreadsheet This blog is about pharmacokinetics: Do It Yourself. Only a bit of knowledge of using spreadsheets is required. If you read publications on pharmacokinetics you will have noticed that the model parameters are usually presented in two different notations: clearances V1,V2,V3,Cl,Cl2,Cl3 and time-constants(V1,k10,k21,k12,k13,k31). For a 3 compartment open model these 6 parameters describe the state of the model. To my knowledge the 2 and 3 compartment models with elimination from the central compartment are currently the only models used in modern infusion pumps that are capable of Target Controlled Infusion. For the clearance annotation the parameters consist of the volumes of the compartments V1, V2, V3 and the clearances (vol/time) to the outside: central clearance Cl and inter-compartmental clearances Cl2 and Cl3 often called Q2 and Q3. For the time constant annotation, it is the volume of the central compartment V1 and the time constants in-between de compartments k12 , k21, k13, k31 (/time)
A message from the chairman
My name is Stefan Schraag. Since 2008 I have been chairing the Board of EuroSIVA, a handpicked selection of experts in the field of clinical pharmacology, research and monitoring. Together, we have achieved to establish a team of expertise in many areas of intravenous anaesthesia and target-controlled infusion (TCI). Over the years, this team has devoted time and energy in building and delivering top-class teaching and education through scientific conferences, interactive workshops, clever advisory tools and a variety of publications. All of us have seen people, ideas and concepts coming and going. Maybe the longevity of engaging in TIVA and TCI over now 25 years, has given EuroSIVA the expertise and reputation that remains core to what we do but also retained our healthy scepticism to judge upcoming trends and innovations. However, all of us grow older and some have already jumped over the fence of retirement. Nonetheless, all members of the Board have retained their expertise and are engaging
What to expect: the pre-blog
Using my prerogative as webmaster I open this blog to inform you on the purpose and features of the blog. In the Eurosiva-blog the individual board members will write what keeps them busy or what they think is interesting for IV and not so IV enthusiast colleagues. We plan to update this post at least every 4 weeks. Topics could be news from the meetings, from the different projects, a comment on an article and so on. We may also invite non board members to post in our blog. Before publishing, the post will be read and aproved by at least one co-board member. We also added the possibility to comment on the blog. We will respect your privacy and will not share your email address, but if you want you can log in anonymously. We will however remove comments that are inappropriate or otherwise not supportive for an open discussion. The Eurosiva does not have a commercial connection with